# 352. Chris Kiple, CEO of Solius Labs

Page: https://stenobird.com/podcast/fitt-insider-254580/352-chris-kiple-ceo-of-solius-labs
Text version: https://stenobird.com/podcast/fitt-insider-254580/352-chris-kiple-ceo-of-solius-labs.md
Podcast: [Fitt Insider](https://stenobird.com/podcast/fitt-insider-254580)
Published: 2026-08-17T08:30:00+00:00
Episode link: https://fittinsider.libsyn.com/352-chris-kiple-ceo-of-solius-labs
Audio file: https://traffic.libsyn.com/secure/fittinsider/352_-_Solius.mp3?dest-id=1477619
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/fitt-insider-254580/episodes/352-chris-kiple-ceo-of-solius-labs
Duration seconds: 2307

## Resource

Today, I'm joined by Chris Kiple, CEO of Solius Labs. A decade in development, Solius's FDA-cleared UVB light therapy device personalizes dosage by skin type, aiming to replicate the benefits of sunlight while minimizing carcinogenic risk. In this episode, we discuss sunlight as a foundational pillar of health and longevity. We also cover: Why sun avoidance is deadlier than smoking Designing a skin scanner for personalized UVB dosing Moving UVB therapy from clinical dermatology to consumer health Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider Website: www.solius.com Instagram: https://www.instagram.com/soliuslabs - The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities. Fitt Talent: https://talent.fitt.co/ Consulting: https://consulting.fitt.co/ Investments: https://capital.fitt.co/ Chapters: (00:00) Introduction (00:29) Swedish longevity study (01:20) Chris background and Solius overview (02:05) UVB light therapy foundation (04:00) 10-year development and timing (05:07) Sun exposure evolution and skin type (08:10) Solius technology and personalized dosing (09:35) Skin scanning and dosing mechanism (11:00) FDA clearance and safety focus (12:40) OTC vs. prescription positioning (14:15) Safety risk contextualization (15:42) Healthcare partnerships strategy (17:50) Dermatology focus (19:00) Orthopedic and cardiovascular applications (20:32) Longevity clinic partnerships (22:35) Swedish and UK biobank studies (26:00) Hormone production benefits (27:20) Cardiovascular and nitric oxide improvements (28:30) Microbiome diversity impact (31:15) Platform evolution and fut…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/fitt-insider-254580/episodes/352-chris-kiple-ceo-of-solius-labs/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/fitt-insider-254580/352-chris-kiple-ceo-of-solius-labs.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.